Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Congy

Showing results (121-130 of 150) with videos related to

Pageof 15
Sort By:
Journal of Translational Autoimmunity|February 3, 2025
Across ancestries, HLA-B∗08:01∼DRB1∗03:01 (DR3) and HLA-DQA∗01:02 (DR2) increase the risk to develop juvenile-onset systemic lupus erythematosus through low complement C4 levelsYves Renaudineau, Amandine Charras, Valentina Natoli, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 20, 2022
Impact of calcineurin inhibitor-free immunosuppression on de novo donor-specific antibody formation in liver transplant recipientsMagdalena Meszaros, Valérie Dubois, Nicolas Congy-Jolivet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 17, 2013
ADAM17-mediated shedding of FcγRIIIA on human NK cells: identification of the cleavage site and relationship with activationLaurie Lajoie, Nicolas Congy-Jolivet, Armelle Bolzec, et al.
BMC Anesthesiology|July 19, 2019
Outcomes of kidney transplant recipients admitted to the intensive care unit: a retrospective study of 200 patientsDamien Guinault, Arnaud Del Bello, Laurence Lavayssiere, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 8, 2004
SR147778 [5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide], a new potent and selective antagonist of the CB1 cannabinoid receptor: biochemical and pharmacological characterizationMurielle Rinaldi-Carmona, Francis Barth, Christian Congy, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|April 14, 2016
Successful Transplantation in ABO- and HLA-Incompatible Living Kidney Transplant Patients: A Report on 12 CasesLionel Rostaing, Béatrice Karam, Nicolas Congy-Jolivet, et al.
Haematologica|September 18, 2025
Anti-HLA class I IgG subclasses skew platelet activation mechanisms in transfusion refractorinessAdèle Couvidou, Mathieu Wald, Catherine Angénieux, et al.
Scientific Reports|May 10, 2018
Whole genome sequencing in the search for genes associated with the control of SIV infection in the Mauritian macaque modelMarc de Manuel, Takashi Shiina, Shingo Suzuki, et al.
Pharmaceutical Research|November 22, 2007
Aerodynamical, immunological and pharmacological properties of the anticancer antibody cetuximab following nebulizationAgnès Maillet, Nicolas Congy-Jolivet, Sandrine Le Guellec, et al.
Transplantation|August 12, 2015
Deleterious Impact of Donor-Specific Anti-HLA Antibodies Toward HLA-Cw and HLA-DP in Kidney TransplantationThomas Bachelet, Charlie Martinez, Arnaud Del Bello, et al.
Pageof 15

Showing results (121-130 of 150) with videos related to

Sort By:
Pageof 15
Journal of Translational Autoimmunity|February 3, 2025
Across ancestries, HLA-B∗08:01∼DRB1∗03:01 (DR3) and HLA-DQA∗01:02 (DR2) increase the risk to develop juvenile-onset systemic lupus erythematosus through low complement C4 levelsYves Renaudineau, Amandine Charras, Valentina Natoli, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 20, 2022
Impact of calcineurin inhibitor-free immunosuppression on de novo donor-specific antibody formation in liver transplant recipientsMagdalena Meszaros, Valérie Dubois, Nicolas Congy-Jolivet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 17, 2013
ADAM17-mediated shedding of FcγRIIIA on human NK cells: identification of the cleavage site and relationship with activationLaurie Lajoie, Nicolas Congy-Jolivet, Armelle Bolzec, et al.
BMC Anesthesiology|July 19, 2019
Outcomes of kidney transplant recipients admitted to the intensive care unit: a retrospective study of 200 patientsDamien Guinault, Arnaud Del Bello, Laurence Lavayssiere, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 8, 2004
SR147778 [5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide], a new potent and selective antagonist of the CB1 cannabinoid receptor: biochemical and pharmacological characterizationMurielle Rinaldi-Carmona, Francis Barth, Christian Congy, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|April 14, 2016
Successful Transplantation in ABO- and HLA-Incompatible Living Kidney Transplant Patients: A Report on 12 CasesLionel Rostaing, Béatrice Karam, Nicolas Congy-Jolivet, et al.
Haematologica|September 18, 2025
Anti-HLA class I IgG subclasses skew platelet activation mechanisms in transfusion refractorinessAdèle Couvidou, Mathieu Wald, Catherine Angénieux, et al.
Scientific Reports|May 10, 2018
Whole genome sequencing in the search for genes associated with the control of SIV infection in the Mauritian macaque modelMarc de Manuel, Takashi Shiina, Shingo Suzuki, et al.
Pharmaceutical Research|November 22, 2007
Aerodynamical, immunological and pharmacological properties of the anticancer antibody cetuximab following nebulizationAgnès Maillet, Nicolas Congy-Jolivet, Sandrine Le Guellec, et al.
Transplantation|August 12, 2015
Deleterious Impact of Donor-Specific Anti-HLA Antibodies Toward HLA-Cw and HLA-DP in Kidney TransplantationThomas Bachelet, Charlie Martinez, Arnaud Del Bello, et al.
Pageof 15